HKSE - Delayed Quote HKD

WuXi XDC Cayman Inc. (2268.HK)

38.250
-0.250
(-0.65%)
As of 9:20:14 AM GMT+8. Market Open.
Currency in CNY All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
4,052,320
4,052,320
2,123,839
990,423
311,131
Cost of Revenue
2,812,474
2,812,474
1,564,281
729,340
197,637
Gross Profit
1,239,846
1,239,846
559,558
261,083
113,494
Operating Expense
291,311
291,311
157,655
119,411
53,362
Operating Income
948,535
948,535
401,903
141,672
60,132
Net Non Operating Interest Income Expense
181,981
181,981
46,621
1,696
-465
Pretax Income
1,219,791
1,219,791
359,612
195,801
66,853
Tax Provision
150,169
150,169
76,074
40,070
11,923
Net Income Common Stockholders
1,069,622
1,069,622
283,538
155,731
54,930
Diluted NI Available to Com Stockholders
1,069,622
1,069,622
283,538
155,731
54,930
Basic EPS
0.89
--
0.28
0.13
0.05
Diluted EPS
0.83
--
0.26
0.13
0.05
Basic Average Shares
1,198,444.240
--
1,022,997.484
1,178,446
1,178,446
Diluted Average Shares
1,288,235.235
--
1,077,972.938
1,178,446
1,178,446
Total Expenses
3,103,785
3,103,785
1,721,936
848,751
250,999
Net Income from Continuing & Discontinued Operation
1,069,622
1,069,622
283,538
155,731
54,930
Normalized Income
1,065,905.742
1,065,905.742
321,411.452
155,731
54,930
Interest Income
185,186
185,186
47,363
4,612
28
Interest Expense
3,205
3,205
742
2,916
493
Net Interest Income
181,981
181,981
46,621
1,696
-465
EBIT
1,222,996
1,222,996
360,354
198,717
67,346
EBITDA
1,333,384
1,333,384
419,867
229,529
86,327
Reconciled Cost of Revenue
2,812,474
2,812,474
1,564,281
729,340
197,637
Reconciled Depreciation
110,388
110,388
59,513
30,812
18,981
Net Income from Continuing Operation Net Minority Interest
1,069,622
1,069,622
283,538
155,731
54,930
Total Unusual Items Excluding Goodwill
4,238
4,238
-48,035
0
0
Total Unusual Items
4,238
4,238
-48,035
0
0
Normalized EBITDA
1,329,146
1,329,146
467,902
229,529
86,327
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
521.742
521.742
-10,161.548
0
0
12/31/2021 - 11/17/2023

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

2359.HK WuXi AppTec Co., Ltd.
64.300
+1.71%
 
688193.SS Shanghai Rendu Biotechnology Co., Ltd.
37.97
-1.48%
 
603108.SS Shanghai Runda Medical Technology Co., Ltd.
19.28
-1.18%
 
603259.SS WuXi AppTec Co., Ltd.
61.03
+1.95%
 
WUXAY WuXi AppTec Co., Ltd.
8.21
+3.01%
 
TWST Twist Bioscience Corporation
29.52
-8.58%
 
GH Guardant Health, Inc.
40.72
-1.55%
 
NTRA Natera, Inc.
151.34
-0.62%
 
GRAL GRAIL, Inc.
32.89
-23.32%
 
DHR Danaher Corporation
187.82
-4.47%